Global Chemotherapy-induced Nausea and Vomiting Drugs Market Research Report 2020


The global Chemotherapy-induced Nausea and Vomiting Drugs market is valued at US$ 82 million in 2020 is expected to reach US$ 124.9 million by the end of 2026, growing at a CAGR of 6.1% during 2021-2026.
This report focuses on Chemotherapy-induced Nausea and Vomiting Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Chemotherapy-induced Nausea and Vomiting Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
Market Segment Analysis
The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type, the Chemotherapy-induced Nausea and Vomiting Drugs market is segmented into
    5-HT3 Inhibitors
    NK1 Inhibitors
    Other

Segment by Application
    Highly Emetogenic Chemotherapy
    Moderately Emetogenic Chemotherapy
    Low Emetogenic Chemotherapy
    Other

 Global Chemotherapy-induced Nausea and Vomiting Drugs Market: Regional Analysis
The Chemotherapy-induced Nausea and Vomiting Drugs market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the Chemotherapy-induced Nausea and Vomiting Drugs market report are:
North America
    U.S.
    Canada
Europe
    Germany
    France
    U.K.
    Italy
    Russia
Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
Latin America
    Mexico
    Brazil
    Argentina
Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E
Global Chemotherapy-induced Nausea and Vomiting Drugs Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Chemotherapy-induced Nausea and Vomiting Drugs market include:
    Merck
    Eisai
    Mundipharma
    Qilu Pharma
    Teva
    Novartis
    Heron Therapeutics
    Roche
    Mylan
    Tesaro
Table of Contents

1 Chemotherapy-induced Nausea and Vomiting Drugs Market Overview
    1.1 Product Overview and Scope of Chemotherapy-induced Nausea and Vomiting Drugs
    1.2 Chemotherapy-induced Nausea and Vomiting Drugs Segment by Type
        1.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate Comparison by Type (2021-2026)
        1.2.2 5-HT3 Inhibitors
        1.2.3 NK1 Inhibitors
        1.2.4 Other
    1.3 Chemotherapy-induced Nausea and Vomiting Drugs Segment by Application
        1.3.1 Chemotherapy-induced Nausea and Vomiting Drugs Sales Comparison by Application: 2020 VS 2026
        1.3.2 Highly Emetogenic Chemotherapy
        1.3.3 Moderately Emetogenic Chemotherapy
        1.3.4 Low Emetogenic Chemotherapy
        1.3.5 Other
    1.4 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Estimates and Forecasts
        1.4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue 2015-2026
        1.4.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales 2015-2026
        1.4.3 Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Region: 2020 Versus 2026

2 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Competition by Manufacturers
    2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturers (2015-2020)
    2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Manufacturers (2015-2020)
    2.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Average Price by Manufacturers (2015-2020)
    2.4 Manufacturers Chemotherapy-induced Nausea and Vomiting Drugs Manufacturing Sites, Area Served, Product Type
    2.5 Chemotherapy-induced Nausea and Vomiting Drugs Market Competitive Situation and Trends
        2.5.1 Chemotherapy-induced Nausea and Vomiting Drugs Market Concentration Rate
        2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
        2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    2.7 Primary Interviews with Key Chemotherapy-induced Nausea and Vomiting Drugs Players (Opinion Leaders)

3 Chemotherapy-induced Nausea and Vomiting Drugs Retrospective Market Scenario by Region
    3.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    3.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
    3.3 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Country
        3.3.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
        3.3.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Country
        3.4.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
        3.4.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Region
        3.5.1 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region
        3.5.2 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Country
        3.6.1 Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
        3.6.2 Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
        3.6.3 Mexico
        3.6.3 Brazil
        3.6.3 Argentina
    3.7 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Facts & Figures by Country
        3.7.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
        3.7.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Chemotherapy-induced Nausea and Vomiting Drugs Historic Market Analysis by Type
    4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Type (2015-2020)
    4.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Type (2015-2020)
    4.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Price Market Share by Type (2015-2020)
    4.4 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Chemotherapy-induced Nausea and Vomiting Drugs Historic Market Analysis by Application
    5.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Application (2015-2020)
    5.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Application (2015-2020)
    5.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Application (2015-2020)

6 Company Profiles and Key Figures in Chemotherapy-induced Nausea and Vomiting Drugs Business
    6.1 Merck
        6.1.1 Corporation Information
        6.1.2 Merck Description, Business Overview and Total Revenue
        6.1.3 Merck Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.1.4 Merck Products Offered
        6.1.5 Merck Recent Development
    6.2 Eisai
        6.2.1 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        6.2.2 Eisai Description, Business Overview and Total Revenue
        6.2.3 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.2.4 Eisai Products Offered
        6.2.5 Eisai Recent Development
    6.3 Mundipharma
        6.3.1 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        6.3.2 Mundipharma Description, Business Overview and Total Revenue
        6.3.3 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.3.4 Mundipharma Products Offered
        6.3.5 Mundipharma Recent Development
    6.4 Qilu Pharma
        6.4.1 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        6.4.2 Qilu Pharma Description, Business Overview and Total Revenue
        6.4.3 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Qilu Pharma Products Offered
        6.4.5 Qilu Pharma Recent Development
    6.5 Teva
        6.5.1 Teva Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        6.5.2 Teva Description, Business Overview and Total Revenue
        6.5.3 Teva Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.5.4 Teva Products Offered
        6.5.5 Teva Recent Development
    6.6 Novartis
        6.6.1 Novartis Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        6.6.2 Novartis Description, Business Overview and Total Revenue
        6.6.3 Novartis Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.6.4 Novartis Products Offered
        6.6.5 Novartis Recent Development
    6.7 Heron Therapeutics
        6.6.1 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        6.6.2 Heron Therapeutics Description, Business Overview and Total Revenue
        6.6.3 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.4.4 Heron Therapeutics Products Offered
        6.7.5 Heron Therapeutics Recent Development
    6.8 Roche
        6.8.1 Roche Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        6.8.2 Roche Description, Business Overview and Total Revenue
        6.8.3 Roche Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.8.4 Roche Products Offered
        6.8.5 Roche Recent Development
    6.9 Mylan
        6.9.1 Mylan Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        6.9.2 Mylan Description, Business Overview and Total Revenue
        6.9.3 Mylan Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.9.4 Mylan Products Offered
        6.9.5 Mylan Recent Development
    6.10 Tesaro
        6.10.1 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        6.10.2 Tesaro Description, Business Overview and Total Revenue
        6.10.3 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Gross Margin (2015-2020)
        6.10.4 Tesaro Products Offered
        6.10.5 Tesaro Recent Development

7 Chemotherapy-induced Nausea and Vomiting Drugs Manufacturing Cost Analysis
    7.1 Chemotherapy-induced Nausea and Vomiting Drugs Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Raw Materials Price Trend
       7.1.3 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Chemotherapy-induced Nausea and Vomiting Drugs
    7.4 Chemotherapy-induced Nausea and Vomiting Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Chemotherapy-induced Nausea and Vomiting Drugs Distributors List
    8.3 Chemotherapy-induced Nausea and Vomiting Drugs Customers

9 Market Dynamics
    9.1 Market Trends
    9.2 Opportunities and Drivers
    9.3 Challenges
    9.4 Porter's Five Forces Analysis

10 Global Market Forecast
    10.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Chemotherapy-induced Nausea and Vomiting Drugs by Type (2021-2026)
        10.1.2 Global Forecasted Revenue of Chemotherapy-induced Nausea and Vomiting Drugs by Type (2021-2026)
    10.2 Chemotherapy-induced Nausea and Vomiting Drugs Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Chemotherapy-induced Nausea and Vomiting Drugs by Application (2021-2026)
        10.2.2 Global Forecasted Revenue of Chemotherapy-induced Nausea and Vomiting Drugs by Application (2021-2026)
    10.3 Chemotherapy-induced Nausea and Vomiting Drugs Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Chemotherapy-induced Nausea and Vomiting Drugs by Region (2021-2026)
        10.3.2 Global Forecasted Revenue of Chemotherapy-induced Nausea and Vomiting Drugs by Region (2021-2026)
    10.4 North America Chemotherapy-induced Nausea and Vomiting Drugs Estimates and Projections (2021-2026)
    10.5 Europe Chemotherapy-induced Nausea and Vomiting Drugs Estimates and Projections (2021-2026)
    10.6 Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Estimates and Projections (2021-2026)
    10.7 Latin America Chemotherapy-induced Nausea and Vomiting Drugs Estimates and Projections (2021-2026)
    10.8 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables Table 1. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers Covered in This Study Table 5. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Manufacturers (2015-2020) Table 7. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Chemotherapy-induced Nausea and Vomiting Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Chemotherapy-induced Nausea and Vomiting Drugs Sales Sites and Area Served Table 11. Manufacturers Chemotherapy-induced Nausea and Vomiting Drugs Product Types Table 12. Global Chemotherapy-induced Nausea and Vomiting Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Chemotherapy-induced Nausea and Vomiting Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotherapy-induced Nausea and Vomiting Drugs as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Chemotherapy-induced Nausea and Vomiting Drugs Players Table 16. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) by Region (2015-2020) Table 17. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Region (2015-2020) Table 18. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Million US$) by Region (2015-2020) Table 19. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Region (2015-2020) Table 20. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2015-2020) (K Units) Table 21. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Country (2015-2020) Table 22. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Country (2015-2020) (US$ Million) Table 23. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Country (2015-2020) Table 24. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2015-2020) (K Units) Table 25. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Country (2015-2020) Table 26. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Region (2015-2020) Table 32. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2015-2020) (K Units) Table 33. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Country (2015-2020) Table 34. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Country (2015-2020) Table 40. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) by Type (2015-2020) Table 41. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Type (2015-2020) Table 42. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Million US$) by Type (2015-2020) Table 43. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Type (2015-2020) Table 44. Global Chemotherapy-induced Nausea and Vomiting Drugs Price (USD/Unit) by Type (2015-2020) Table 45. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) by Application (2015-2020) Table 46. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Application (2015-2020) Table 47. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate by Application (2015-2020) Table 48. Merck Chemotherapy-induced Nausea and Vomiting Drugs Corporation Information Table 49. Merck Description and Business Overview Table 50. Merck Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. Merck Main Product Table 52. Merck Recent Development Table 53. Eisai Chemotherapy-induced Nausea and Vomiting Drugs Corporation Information Table 54. Eisai Corporation Information Table 55. Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Eisai Main Product Table 57. Eisai Recent Development Table 58. Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Corporation Information Table 59. Mundipharma Corporation Information Table 60. Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Mundipharma Main Product Table 62. Mundipharma Recent Development Table 63. Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Corporation Information Table 64. Qilu Pharma Corporation Information Table 65. Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Qilu Pharma Main Product Table 67. Qilu Pharma Recent Development Table 68. Teva Chemotherapy-induced Nausea and Vomiting Drugs Corporation Information Table 69. Teva Corporation Information Table 70. Teva Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. Teva Main Product Table 72. Teva Recent Development Table 73. Novartis Chemotherapy-induced Nausea and Vomiting Drugs Corporation Information Table 74. Novartis Corporation Information Table 75. Novartis Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Novartis Main Product Table 77. Novartis Recent Development Table 78. Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Corporation Information Table 79. Heron Therapeutics Corporation Information Table 80. Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Heron Therapeutics Main Product Table 82. Heron Therapeutics Recent Development Table 83. Roche Chemotherapy-induced Nausea and Vomiting Drugs Corporation Information Table 84. Roche Corporation Information Table 85. Roche Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 86. Roche Main Product Table 87. Roche Recent Development Table 88. Mylan Chemotherapy-induced Nausea and Vomiting Drugs Corporation Information Table 89. Mylan Corporation Information Table 90. Mylan Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 91. Mylan Main Product Table 92. Mylan Recent Development Table 93. Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Corporation Information Table 94. Tesaro Corporation Information Table 95. Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 96. Tesaro Main Product Table 97. Tesaro Recent Development Table 98. Sales Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Chemotherapy-induced Nausea and Vomiting Drugs Distributors List Table 101. Chemotherapy-induced Nausea and Vomiting Drugs Customers List Table 102. Market Key Trends Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 104. Key Challenges Table 105. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Type (2021-2026) Table 106. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share Forecast by Type (2021-2026) Table 107. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Million US$) Forecast by Type (2021-2026) Table 108. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 109. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Application (2021-2026) Table 110. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Million US$) Forecast by Application (2021-2026) Table 111. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) Forecast by Region (2021-2026) Table 112. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share Forecast by Region (2021-2026) Table 113. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 114. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share Forecast by Region (2021-2026) Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Chemotherapy-induced Nausea and Vomiting Drugs Figure 2. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Type: 2020 VS 2026 Figure 3. 5-HT3 Inhibitors Product Picture Figure 4. NK1 Inhibitors Product Picture Figure 5. Other Product Picture Figure 6. Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Share by Application: 2020 VS 2026 Figure 7. Highly Emetogenic Chemotherapy Figure 8. Moderately Emetogenic Chemotherapy Figure 9. Low Emetogenic Chemotherapy Figure 10. Other Figure 11. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size 2015-2026 (US$ Million) Figure 12. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Capacity (K Units) (2015-2026) Figure 13. Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 14. Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Manufacturers in 2020 Figure 15. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Manufacturers in 2019 Figure 16. The Global 5 and 10 Largest Players: Market Share by Chemotherapy-induced Nausea and Vomiting Drugs Revenue in 2019 Figure 17. Chemotherapy-induced Nausea and Vomiting Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Region (2015-2020) Figure 19. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Region in 2019 Figure 20. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Region (2015-2020) Figure 21. Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Region in 2019 Figure 22. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Country in 2019 Figure 23. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Country in 2019 Figure 24. U.S. Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 25. U.S. Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Canada Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 27. Canada Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 28. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Country in 2019 Figure 29. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Country in 2019 Figure 30. Germany Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 31. Germany Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. France Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 33. France Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. U.K. Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 35. U.K. Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Italy Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 37. Italy Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Russia Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 39. Russia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Region in 2019 Figure 41. Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Region in 2019 Figure 42. China Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 43. China Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. Japan Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 45. Japan Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. South Korea Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 47. South Korea Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. India Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 49. India Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Australia Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 51. Australia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Taiwan Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 53. Taiwan Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Indonesia Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 55. Indonesia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Thailand Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 57. Thailand Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Malaysia Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 59. Malaysia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Philippines Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 61. Philippines Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Vietnam Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 63. Vietnam Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Country in 2019 Figure 65. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Country in 2019 Figure 66. Mexico Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 67. Mexico Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Brazil Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 69. Brazil Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Argentina Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 71. Argentina Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Country in 2019 Figure 73. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Country in 2019 Figure 74. Turkey Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 75. Turkey Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Saudi Arabia Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 77. Saudi Arabia Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. U.A.E Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth Rate (2015-2020) (K Units) Figure 79. U.A.E Chemotherapy-induced Nausea and Vomiting Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Sales Market Share of Chemotherapy-induced Nausea and Vomiting Drugs by Type (2015-2020) Figure 81. Sales Market Share of Chemotherapy-induced Nausea and Vomiting Drugs by Type in 2019 Figure 82. Revenue Share of Chemotherapy-induced Nausea and Vomiting Drugs by Type (2015-2020) Figure 83. Revenue Market Share of Chemotherapy-induced Nausea and Vomiting Drugs by Type in 2019 Figure 84. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Growth by Type (2015-2020) (K Units) Figure 85. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Application (2015-2020) Figure 86. Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Application in 2019 Figure 87. Global Revenue Share of Chemotherapy-induced Nausea and Vomiting Drugs by Application (2015-2020) Figure 88. Global Revenue Share of Chemotherapy-induced Nausea and Vomiting Drugs by Application in 2020 Figure 89. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Eisai Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Mundipharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Qilu Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Heron Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Tesaro Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Price Trend of Key Raw Materials Figure 100. Manufacturing Cost Structure of Chemotherapy-induced Nausea and Vomiting Drugs Figure 101. Manufacturing Process Analysis of Chemotherapy-induced Nausea and Vomiting Drugs Figure 102. Chemotherapy-induced Nausea and Vomiting Drugs Industrial Chain Analysis Figure 103. Channels of Distribution Figure 104. Distributors Profiles Figure 105. Porter's Five Forces Analysis Figure 106. North America Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 107. North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 109. Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 111. Latin America Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 113. Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 115. Asia Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Bottom-up and Top-down Approaches for This Report Figure 117. Data Triangulation Figure 118. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global Core Drill Market Research Report 2020

Global Core Drill Market: Drivers and Restrains The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive ...

Global Computer to Plate (CTP) Equipment Market Research Report 2020

Global Computer to Plate (CTP) Equipment Market: Drivers and Restrains The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the marke...

Global Commercial Food Dehydrators Market Research Report 2020

Global Commercial Food Dehydrators Market: Drivers and Restrains The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in e...

Global Clothes Dryers Market Research Report 2020

Global Clothes Dryers Market: Drivers and Restrains The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a posit...

Global Cathode Active Materials Market Research Report 2020

The global Cathode Active Materials market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Cathode Active Materials volume and value at the...

Publisher: QY Research